NuCana
NCNA
16 hedge funds and large institutions have $148M invested in NuCana in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
5.05% less ownership
Funds ownership: 19.94% → 14.89% (-5.1%)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
25% less capital invested
Capital invested by funds: $197M → $148M (-$49.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$34.6M |
| 2 |
WIM
Woodford Investment Management
London,
United Kingdom
|
+$2.22M |
| 3 |
JG
Jefferies Group
New York
|
+$739K |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$369K |
| 5 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$246K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$98.5M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$2.59M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$616K |
| 4 |
UBS AM
Chicago,
Illinois
|
-$616K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$369K |
NCNA Hedge Fund Activity: Q2 2018 in Review
16 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in NuCana (NCNA) for Q2 2018, worth a combined $148M — down 25% from $197M a quarter earlier.
Fund positioning in NCNA was balanced in Q2 2018: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 6 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $34.6M. The largest seller was Sofinnova Investments, cutting an estimated $98.5M.
- 16 institutional investors held NuCana (NCNA) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $148M of NuCana stock for Q2 2018, down 25% quarter-over-quarter.
- 1 fund opened new NuCana positions in Q2 2018 and 1 closed out, a net change of 0 holders.
- The largest NuCana buyer in Q2 2018 was Capital Research Global Investors, an estimated $34.6M added.
- The largest NuCana seller in Q2 2018 was Sofinnova Investments, an estimated $98.5M sold.
Based on aggregated 13F filings for Q2 2018.